Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hamps BioBOM:544312 -2.17%12 Market Cap is ₹196.02 Mil as of Aug. 20, 2026. GuruFocus rates BOM:544312 with a GF Score™ of 12/100. The stock has 4 warning signs investors should review. Among 690 Healthcare Providers & Services companies, Hamps Bio ranks worse than 94.78% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Hamps Bio's share price for the quarter that ended in Mar. 2026 was ₹16.55. Hamps Bio's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 8.71 Mil. Therefore, Hamps Bio's market cap for the quarter that ended in Mar. 2026 was ₹144.18 Mil.
Hamps Bio's quarterly market cap
declined
from Mar. 2025 (₹186.22 Mil) to Sep. 2025 (₹184.96 Mil) and
declined
from Sep. 2025 (₹184.96 Mil) to Mar. 2026 (₹144.18 Mil).
Hamps Bio's annual market cap
increased
from Mar. 2024 (₹0.00 Mil) to Mar. 2025 (₹186.22 Mil) but then
declined
from Mar. 2025 (₹186.22 Mil) to Mar. 2026 (₹144.18 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Hamps Bio's Enterprise Value for Today is ₹263.15 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Hamps Bio Market Cap Related Terms
Hamps Bio Market Cap Historical Data
* Premium members only.
The historical data trend for Hamps Bio's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Hamps Bio's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hamps Bio Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hamps Bio's Market Cap distribution charts can be found below:
* The bar in red indicates where Hamps Bio's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Hamps Bio's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hamps Bio (BOM:544312) has a Market Cap of ₹196.02 Mil as of Aug. 20, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Hamps Bio and its competitors. According to the industry distribution chart, Hamps Bio ranks #654 out of 690 companies in the Healthcare Providers & Services industry, placing it in the top 94.8%.
Is Hamps Bio's Market Cap too high?
Hamps Bio's current Market Cap is ₹196.02 Mil. Based on the distribution chart, Hamps Bio ranks #654 out of 690 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Hamps Bio has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Hamps Bio's Market Cap compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Hamps Bio ranks #654 out of 690 companies for Market Cap. This places Hamps Bio in the lower half of its industry. The industry median Market Cap is 106.24. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 106.24, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Hamps Bio and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 106.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hamps Bio's current Market Cap is ₹196.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hamps Bio stock overvalued right now?
Hamps Bio (BOM:544312) has a current Market Cap of ₹196.02 Mil. The current Market Cap is ₹196.02 Mil. Hamps Bio's overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Hamps Bio (BOM:544312), the current Market Cap is ₹196.02 Mil as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hamps Bio Ltd is engaged in the ethical marketing and distribution of pharmaceutical formulation products. Its product include tablets, syrups, capsules, injectables, oil, gel and powder used as medicine and nutrition supplements as well as the manufacturing of freeze dried and frozen products such as fruits, vegetables, herbs and flowers. The company segment includes Manufacturing, trading and distribution of Pharmaceutical formulation products and Manufacturing of Freeze dried and frozen products like fruits, vegetables, herbs, flowers, etc. Key revenue is generated from Medicine Products.
12GF Score
Get the complete analysis for BOM:544312
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544312 has been successfully added to your 
